176 related articles for article (PubMed ID: 22207577)
21. Hyperoxaluric rats do not exhibit alterations in renal expression patterns of Slc26a1 (SAT1) mRNA or protein.
Freel RW; Hatch M
Urol Res; 2012 Dec; 40(6):647-54. PubMed ID: 22573180
[TBL] [Abstract][Full Text] [Related]
22. L-Hydroxyproline and d-Proline Catabolism in Sinorhizobium meliloti.
Chen S; White CE; diCenzo GC; Zhang Y; Stogios PJ; Savchenko A; Finan TM
J Bacteriol; 2016 Feb; 198(7):1171-81. PubMed ID: 26833407
[TBL] [Abstract][Full Text] [Related]
23. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
[TBL] [Abstract][Full Text] [Related]
24. 4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
Riedel TJ; Knight J; Murray MS; Milliner DS; Holmes RP; Lowther WT
Biochim Biophys Acta; 2012 Oct; 1822(10):1544-52. PubMed ID: 22771891
[TBL] [Abstract][Full Text] [Related]
25. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
Belostotsky R; Pitt JJ; Frishberg Y
J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
[TBL] [Abstract][Full Text] [Related]
26. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
Monico CG; Persson M; Ford GC; Rumsby G; Milliner DS
Kidney Int; 2002 Aug; 62(2):392-400. PubMed ID: 12110000
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of LhpR in control of hydroxyproline catabolism and transport in Pseudomonas aeruginosa PAO1.
Li G; Lu CD
Microbiology (Reading); 2016 Jul; 162(7):1232-1242. PubMed ID: 27145750
[TBL] [Abstract][Full Text] [Related]
28. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats.
Green ML; Freel RW; Hatch M
Kidney Int; 2005 Dec; 68(6):2629-38. PubMed ID: 16316339
[TBL] [Abstract][Full Text] [Related]
29. Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment.
Belostotsky R; Frishberg Y
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055190
[TBL] [Abstract][Full Text] [Related]
30. New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production.
Moya-Garzon MD; Rodriguez-Rodriguez B; Martin-Higueras C; Franco-Montalban F; Fernandes MX; Gomez-Vidal JA; Pey AL; Salido E; Diaz-Gavilan M
Eur J Med Chem; 2022 Jul; 237():114396. PubMed ID: 35500475
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a New Gas Chromatography-Tandem Mass Spectrometry Method for the Measurement of Enrichment of Glyoxylate Metabolism Analytes in Hyperoxaluria Patients Using a Stable Isotope Procedure.
van Harskamp D; Garrelfs SF; Oosterveld MJS; Groothoff JW; van Goudoever JB; Schierbeek H
Anal Chem; 2020 Jan; 92(2):1826-1832. PubMed ID: 31867958
[TBL] [Abstract][Full Text] [Related]
32. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
[TBL] [Abstract][Full Text] [Related]
33. Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.
Martin-Higueras C; Luis-Lima S; Salido E
Mol Ther; 2016 Apr; 24(4):719-25. PubMed ID: 26689264
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.
Cregeen DP; Williams EL; Hulton S; Rumsby G
Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635115
[TBL] [Abstract][Full Text] [Related]
35. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
Whittamore JM; Stephens CE; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
[TBL] [Abstract][Full Text] [Related]
36. Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria.
Frishberg Y; Zeharia A; Lyakhovetsky R; Bargal R; Belostotsky R
J Med Genet; 2014 Aug; 51(8):526-9. PubMed ID: 24996905
[TBL] [Abstract][Full Text] [Related]
37. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
Scheinman JI; Voziyan PA; Belmont JM; Chetyrkin SV; Kim D; Hudson BG
Urol Res; 2005 Nov; 33(5):368-71. PubMed ID: 16292584
[TBL] [Abstract][Full Text] [Related]
38. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
[TBL] [Abstract][Full Text] [Related]
39. Primary hyperoxaluria type 1 in Japan.
Ichiyama A; Oda T; Maeda-Nakai E
Cell Biochem Biophys; 2000; 32 Spring():171-6. PubMed ID: 11330044
[TBL] [Abstract][Full Text] [Related]
40. Pathways of hepatic oxalate synthesis and their regulation.
Poore RE; Hurst CH; Assimos DG; Holmes RP
Am J Physiol; 1997 Jan; 272(1 Pt 1):C289-94. PubMed ID: 9038835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
